Spero Share Price

Spero Share Price

NASDAQ: SPRO | Micro Cap | Healthcare
$0.87
-$0.02 (-2.74%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Spero Stock Performance

Open
$0.92
Prev. Close
$0.90
Circuit Range
N/A
Day Range
$0.88 - $0.92
Year Range
$0.88 - $3.07
Volume
7,620
Average Traded
$0.90

Spero Share Price Today

As of 19 November 2026, Spero Therapeutics, Inc.'s share price is $0.87. The stock opened at $0.92, compared to its previous close of $0.90. During today's trading session, Spero Therapeutics, Inc.'s share price traded between $0.88 and $0.92, with an average price of $0.90. Over the past 52 weeks, the stock has recorded a high of $3.07 and a low of $0.88. In terms of performance, Spero Therapeutics, Inc.'s share price has declined by 69.11% over the last six months and is down 63.71% on a year-on-year basis.

Spero Share Price Chart

Line chart of the Spero price trend over the selected period. The price fell overall, ranging from 0.87 to 0.92, ending at 0.87.
$0.88$0.92
L
Show Current Price
H

Spero Stock Fundamentals & Key Indicators

Market Cap
$48.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.51
Revenue (TTM)
$66.80B
Return On Equity (TTM)
-3778.87%
Profit Margin
12.83%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-240.48%

Spero Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$41.30$0.26$0.00$0.00
Net Profit$31.52-$7.20-$9.55-$44.28
Net Profit Margin76.32%-2769.23%N/AN/A
Income ChangeN/A-122.84%-32.64%-363.66%

Spero Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$53.51$103.78$47.98$66.80
Net Profit-$46.42$22.81-$68.57$8.57
Net Profit Margin-86.75%21.98%-142.91%12.83%
Income ChangeN/A149.14%-400.61%112.50%

Spero Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.633.2751.1811.23
Current Assets67.29107.28131.21113.57
Total Assets68.92110.54182.39124.8
Non Current Liabilities1.0315.3538.3427.22
Current Liabilities8.8749.0737.1521.65
Total Liabilities9.964.4275.548.87
Shareholders' Equity59.0246.12106.8975.93

Spero Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-12.62-23.44-33.0-6.81
Investing0.00.00.032.89
Financing0.00.00.22-29.55

About Spero

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Spero Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.11
$0.88
-16.98%
Oct 2026
$1.20
$1.06
-12.03%
Sep 2026
$1.22
$1.21
-0.82%
Aug 2026
$1.18
$1.22
+2.97%
Jul 2026
$2.22
$1.18
-46.49%
Jun 2026
$2.81
$2.21
-21.81%
May 2026
$2.60
$2.82
+12.13%
Apr 2026
$2.41
$2.52
+7.48%
Mar 2026
$2.15
$2.34
+7.34%
Feb 2026
$2.16
$2.18
-0.23%
Jan 2026
$2.33
$2.19
-6.22%
Dec 2025
$2.31
$2.33
-2.92%

Spero Share Price FAQs